ATE54441T1 - Naphthalenderivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen davon und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

Naphthalenderivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen davon und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE54441T1
ATE54441T1 AT86100282T AT86100282T ATE54441T1 AT E54441 T1 ATE54441 T1 AT E54441T1 AT 86100282 T AT86100282 T AT 86100282T AT 86100282 T AT86100282 T AT 86100282T AT E54441 T1 ATE54441 T1 AT E54441T1
Authority
AT
Austria
Prior art keywords
sup
pharmaceutical compositions
formula
naphthalene derivatives
compounds
Prior art date
Application number
AT86100282T
Other languages
English (en)
Inventor
Tameo Iwasaki
Kohki Takashima
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE54441T1 publication Critical patent/ATE54441T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/337—Polycyclic acids with carboxyl groups bound to condensed ring systems
    • C07C63/34—Polycyclic acids with carboxyl groups bound to condensed ring systems containing two condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Lubricants (AREA)
  • Fats And Perfumes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT86100282T 1985-01-10 1986-01-10 Naphthalenderivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen davon und diese enthaltende pharmazeutische zusammensetzungen. ATE54441T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP309085 1985-01-10
EP86100282A EP0188248B1 (de) 1985-01-10 1986-01-10 Naphthalenderivate, ihr Herstellungsverfahren und pharmazeutische Zusammensetzungen davon und diese enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE54441T1 true ATE54441T1 (de) 1990-07-15

Family

ID=11547645

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86100282T ATE54441T1 (de) 1985-01-10 1986-01-10 Naphthalenderivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen davon und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (18)

Country Link
US (2) US4771072A (de)
EP (1) EP0188248B1 (de)
JP (3) JPS61267541A (de)
KR (1) KR890001884B1 (de)
CN (1) CN1006464B (de)
AT (1) ATE54441T1 (de)
AU (1) AU584153B2 (de)
BG (2) BG45383A3 (de)
DD (1) DD270529A5 (de)
DE (1) DE3672501D1 (de)
ES (2) ES8705837A1 (de)
FI (1) FI87557C (de)
HU (1) HU196737B (de)
IL (1) IL91117A0 (de)
MY (1) MY101268A (de)
NO (1) NO170760C (de)
PH (1) PH22105A (de)
PT (1) PT81814B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011948A (en) * 1985-04-12 1991-04-30 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
JPS6310746A (ja) * 1986-07-01 1988-01-18 Tanabe Seiyaku Co Ltd ナフタレン誘導体
AT388372B (de) * 1987-10-08 1989-06-12 Tanabe Seiyaku Co Neue naphthalinderivate und sie enthaltende pharmazeutika
JPH01135766A (ja) * 1987-11-20 1989-05-29 Tanabe Seiyaku Co Ltd ビフェニル誘導体
PH26342A (en) * 1988-11-29 1992-04-29 Univ Texas Microbial cellulose modified during synthesis
MY105057A (en) * 1989-01-27 1994-07-30 Tanabe Seiyaku Co A process for preparing naphthalene derivatives
ZA9076B (en) * 1989-02-03 1990-10-31 Tanabe Seiyaku Co Limited A process for preparing a naphthalene derivative and a synthetic intermediate thereof
EP0501579A1 (de) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Naphthalinlactone als Inhibitoren der Leukotrien-Biosynthese
EP0501578A1 (de) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Pyranylphenyl-hydroyalkylnaphthalinsäuren als Inhibitoren der Leuktotrien-Biosynthese
US5281720A (en) * 1991-02-28 1994-01-25 Merck Frosst Canada, Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
US5227399A (en) * 1991-02-28 1993-07-13 Merck Frosst Canada, Inc. Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis
ES2129733T3 (es) * 1991-10-17 1999-06-16 Shionogi & Co Procedimiento de preparacion de analogos de la lignina y productos de partida para estos.
US5308852A (en) * 1992-06-29 1994-05-03 Merck Frosst Canada, Inc. Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
US5252599A (en) * 1992-08-27 1993-10-12 Merck Frosst Canada, Inc. Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis
US5426109A (en) * 1992-08-27 1995-06-20 Merck Frosst Canada, Inc. Phenylnaphthalene hydroxy acids
US5428060A (en) * 1992-08-27 1995-06-27 Merck Frosst Canada, Inc. Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5350744A (en) * 1992-08-27 1994-09-27 Merck Frosst Canada, Inc. Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
BR9913333A (pt) * 1998-08-25 2001-05-15 Univ Yale Inibição e tratamento do vìrus da hepatite b e flavivìrus com helioxatina e seus análogos
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
US6646005B1 (en) 1999-06-01 2003-11-11 The University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
JP2003500432A (ja) 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター ジフェニルエーテル誘導体を用いて脱毛症を処置する方法
SE0102168D0 (sv) 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
MXPA04001878A (es) * 2001-08-28 2004-06-15 Sankyo Co Composiciones medicinales que comprenden antagonista del receptor de angiotensina ii.
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP3593802A3 (de) 2010-05-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Gallensäurerückflusshemmer zur behandlung von diabetes, adipositas und entzündlichen magen-darm-erkrankungen
EA201891154A1 (ru) 2011-10-28 2019-02-28 ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей
SG11201401816SA (en) 2011-10-28 2014-05-29 Lumena Pharmaceuticals Inc Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
MX2015013196A (es) 2013-03-15 2016-04-15 Lumena Pharmaceuticals Inc Inhibidores de reciclaje de acidos biliares para el tratamiento de la enfermedad de reflujo gastroesofagico y esofago de barrett.
KR20160002773A (ko) 2013-03-15 2016-01-08 루메나 파마수티컬즈, 인코포레이티드 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제
WO2015153653A1 (en) * 2014-03-31 2015-10-08 Ohio State Innovation Foundation Arylnaphthalene lactone derivatives and methods of making and using thereof
US10682367B2 (en) 2016-02-26 2020-06-16 Ohio State Innovation Foundation Antitumor arylnaphthalene ligand glycosides
BR112021015809A2 (pt) 2019-02-12 2022-01-18 Mirum Pharmaceuticals Inc Resposta dependente de genótipo e dose a um asbti em pacientes com deficiência de bomba de exportação de sal biliar

Also Published As

Publication number Publication date
JPH0272170A (ja) 1990-03-12
KR860005778A (ko) 1986-08-13
BG45383A3 (bg) 1989-05-15
PT81814B (pt) 1988-07-29
NO170760B (no) 1992-08-24
EP0188248B1 (de) 1990-07-11
JPH0272136A (ja) 1990-03-12
PH22105A (en) 1988-06-01
HUT42428A (en) 1987-07-28
EP0188248A2 (de) 1986-07-23
EP0188248A3 (en) 1986-12-17
HU196737B (en) 1989-01-30
AU584153B2 (en) 1989-05-18
KR890001884B1 (ko) 1989-05-29
AU5175185A (en) 1986-07-17
CN1006464B (zh) 1990-01-17
BG45385A3 (bg) 1989-05-15
PT81814A (en) 1986-02-01
IL91117A0 (en) 1990-03-19
FI860089A (fi) 1986-07-11
ES550578A0 (es) 1987-05-16
FI87557C (fi) 1993-01-25
ES557052A0 (es) 1987-12-16
FI860089A0 (fi) 1986-01-09
MY101268A (en) 1991-08-17
US4771072A (en) 1988-09-13
DE3672501D1 (de) 1990-08-16
JPS61267541A (ja) 1986-11-27
DD270529A5 (de) 1989-08-02
US5070103A (en) 1991-12-03
JPH0549668B2 (de) 1993-07-26
ES8801239A1 (es) 1987-12-16
ES8705837A1 (es) 1987-05-16
FI87557B (fi) 1992-10-15
NO855355L (no) 1986-07-11
NO170760C (no) 1992-12-02
CN86100090A (zh) 1986-08-20

Similar Documents

Publication Publication Date Title
ATE54441T1 (de) Naphthalenderivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen davon und diese enthaltende pharmazeutische zusammensetzungen.
DE3773546D1 (de) Naphthalenderivate, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen.
MY102016A (en) Thiazolidinedione derivatives, their production and use.
GEP20043160B (en) Biaryl Ether Derivatives, Pharmaceutical Compositions Containing Them and Their Use as Monoamine Reuptake Inhibitors
DE69132167D1 (de) Kondensierte benzoxa-ringverbindung, deren herstellung sowie diese enthaltendes arzneimittel
HUT45230A (en) Process for producing new phenoxy-acetic acid derivatives and pharmaceuticals comprising such compounds
WO1994014833A3 (en) Substituted 6-azaandrostenones
HU9401161D0 (en) Oxazolidone derivatives, process for producing them and pharmaceutical compositions containing them
CA2053477A1 (en) Heterocyclic amine derivatives, their production and use
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
EP0316939A3 (de) Biphenyl-Derivate, Verfahren zur Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und Verwendung
ES8104269A1 (es) Procedimiento para la preparacion de nuevos derivados de 3-amino-1-benzoxepina
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
US3868463A (en) Method of treating arrhythmia
ES374762A1 (es) Procedimiento para la preparacion de derivado de benzo (b) benzofurano (2,3-e) oxapina.
US3028306A (en) Hypertensive 2-amino-3alpha, 4, 5, 6, 7, 7alpha-hexahydrobenzoxazole method and topical dosage preparation
JPS5695188A (en) Theophyllin derivative and its production
ES2059572T3 (es) Derivado del antibiotico a 42867.
DK644487D0 (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
FR2379505A1 (fr) Nouveaux produits doues notamment de proprietes therapeutiques, leurs procedes de preparation, et medicaments a base de ces produits
RU94031211A (ru) Производные изатина, способ их получения и фармацевтическая композиция на их основе

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee